Nova Leap Health Corp. Re-engages Acquisition Program With Closing of Strategic Acquisition in Massachusetts
Nova Leap Health Corp. Re-engages Acquisition Program With Closing of Strategic Acquisition in Massachusetts
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
不用于在美国传播或分发给美国新闻通讯社
HALIFAX, Nova Scotia, May 06, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has completed the strategic acquisition of a home care business with operations in Massachusetts. The execution of the definitive agreement and related information pertaining to this acquisition was previously announced on April 26, 2024.
新斯科舍省哈利法克斯，2024 年 5 月 6 日（环球新闻专线）— NOVA LEAP HEALTH CORP.多伦多证券交易所股票代码：NLH）（“Nova Leap” 或 “公司”）是一家成长中的家庭医疗保健组织，很高兴地宣布，它已经完成了对一家在马萨诸塞州开展业务的家庭护理公司的战略收购。与本次收购有关的最终协议和相关信息的执行已于2024年4月26日宣布。
"We're pleased to re-engage our acquisition program by completing our first acquisition of 2024," said Chris Dobbin, President & CEO of Nova Leap. "This acquisition complements our existing businesses in Massachusetts and is part of our strategy of expanding our footprint in the region. We're looking forward to working with this tremendous group of individuals as we plan further expansion."
Nova Leap总裁兼首席执行官克里斯·多宾表示：“我们很高兴通过完成2024年的首次收购来重新参与我们的收购计划。”“此次收购补充了我们在马萨诸塞州的现有业务，是我们扩大该地区足迹的战略的一部分。在我们计划进一步扩张时，我们期待与这群庞大的人合作。”
About Nova Leap
Nova Leap is an acquisitive home health care services company operating in one of the fastest-growing industries in the U.S. & Canada. The Company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the #42 and #2 ranking on the 2021 and 2020 Report on Business ranking of Canada's Top Growing Companies and the #10 Ranking in the 2019 TSX Venture 50 in the Clean Technology & Life Sciences sector. The Company is geographically diversified with operations in 8 different U.S. states within the New England, Southeastern, South-Central and Midwest regions as well as Nova Scotia, Canada.
关于 Nova Le
Nova Leap 是一家收购型家庭医疗保健服务公司，业务范围是美国和加拿大增长最快的行业之一。公司以个人和家庭为中心，在持续的护理中发挥着至关重要的作用，尤其是那些需要痴呆症护理的患者。Nova Leap在《2021年和2020年加拿大成长型公司商业报告》排名中获得了 #42 和 #2 排名，在清洁技术和生命科学领域的2019年多伦多证券交易所风险投资50强中获得了#10 排名。该公司的地域多元化，业务遍及美国新英格兰、东南部、中南部和中西部地区以及加拿大新斯科舍省的8个不同州。
FORWARD LOOKING INFORMATION:
前瞻性信息：
Certain information in this press release may contain forward-looking statements, such as statements regarding future expansions and cost savings and plans regarding future acquisitions and business growth, including anticipated annualized revenue or annualized recurring revenue run rate growth and anticipated consolidated Adjusted EBITDA margins. This information is based on current expectations and assumptions, including assumptions described elsewhere in this release and those concerning general economic and market conditions, availability of working capital necessary for conducting Nova Leap's operations, availability of desirable acquisition targets and financing to fund such acquisitions, and Nova Leap's ability to integrate its acquired businesses and maintain previously achieved service hour and revenue levels, that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. Risks that could cause results to differ from those stated in the forward-looking statements in this release include the impact of the COVID-19 pandemic or any recurrence, including staff and supply shortages, regulatory changes affecting the home care industry or government programs utilized by the Company, other unexpected increases in operating costs and competition from other service providers. All forward-looking statements, including any financial outlook or future-oriented financial information, contained in this press release are made as of the date of this release and included for the purpose of providing information about management's current expectations and plans relating to the future, and these statements may not be appropriate for other purposes. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company's filings with the Canadian securities regulators, which filings are available at .
本新闻稿中的某些信息可能包含前瞻性陈述，例如有关未来扩张和成本节约的陈述，以及有关未来收购和业务增长的计划，包括预期的年化收入或年化经常性收入增长率以及预期的合并调整后息税折旧摊销前利润率。这些信息基于当前的预期和假设，包括本新闻稿其他地方描述的假设以及与总体经济和市场状况、开展Nova Leap运营所需的营运资金的可用性、理想收购目标和融资的可用性，以及Nova Leap整合其收购业务和维持先前实现的服务时间和收入水平的能力有关的假设，这些假设都存在难以预测的重大风险和不确定性。实际结果可能与任何前瞻性陈述中建议的结果存在重大差异。可能导致结果与本新闻稿前瞻性陈述中陈述的结果不同的风险包括 COVID-19 疫情或任何复发的影响，包括人员和供应短缺、影响家庭护理行业或公司使用的政府计划的监管变化、运营成本的其他意外增加以及来自其他服务提供商的竞争。本新闻稿中包含的所有前瞻性陈述，包括任何财务展望或面向未来的财务信息，均自本新闻稿发布之日起作出，其包含的目的是提供有关管理层当前预期和未来计划的信息，这些陈述可能不适用于其他目的。除非适用于公司的证券法有要求，否则公司没有义务更新前瞻性陈述，也没有义务更新实际业绩可能与前瞻性陈述中反映的结果不同的原因。识别风险和不确定性的其他信息包含在公司向加拿大证券监管机构提交的文件中，这些文件可在以下网址查阅 。
CAUTIONARY STATEMENT:
警示声明：
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多伦多证券交易所风险投资交易所及其监管服务提供商（该术语在多伦多证券交易所风险交易所的政策中定义）均不对本新闻稿的充分性或准确性承担责任。
CONTACT: For further information: Chris Dobbin, CPA, ICD.D Director, President and CEO Nova Leap Health Corp. T: 902 401 9480 E: cdobbin@novaleaphealth.com
联系人：欲了解更多信息：Chris Dobbin，注册会计师、ICD.D 董事、总裁兼首席执行官 Nova Leap Health Corp. T: 902 401 9480 E: cdobbin@novaleaphealth.com